Vascular responsiveness to exogenous nitrates in type 2 diabetes (T2DM) is attenuated in brachial and coronary vessels. We determined platelet responsiveness to nitric oxide (NO) in T2DM and control subjects. We examined whether the postprandial (PP) state affected platelet sensitivity to NO donors in T2DM patients and the extent of correlation between this and measures of oxidative stress, compared to changes in endothelial function.
Twelve T2DM subjects were studied fasting and four hours after a test meal and compared with 15 healthy controls. We assessed the inhibitory effects of NO donors on adenosine 5′-diphosphate (ADP)-induced platelet aggregation. Oxidative stress was assessed by lipid-derived free radicals, ex vivo by electron paramagnetic resonance spectroscopy and markers of lipid peroxidation. Endothelial function was assessed by flow-mediated vasodilatation (FMD) of the brachial artery.
Results are expressed as (mean±SEM). Fasting platelet aggregation was increased in diabetics versus controls (14.86±1.1 Ohms vs. 10.76±1.1 Ohms, p<0.05). Sodium nitroprusside (SNP) and glyceryl trinitrate (GTN) inhibited ADP-induced aggregation by 73.1±5.9% and 50.3±7.7% in healthy controls compared to 15.4±7% and 19.5±8.2% in T2DM (p<0.05). Fasting and postprandial inhibition of platelet aggregation with NO donors in T2DM was similar. T2DM patients had higher levels of oxidative stress in the fasting state and postprandially. There were no PP correlations with platelet NO resistance.
In conclusion, there is platelet hyporesponsiveness to NO donors (SNP/GTN) in T2DM compared to controls, with increased ADP-induced platelet aggregation. Platelet abnormalities were associated with increased oxidative stress.
1. Stamler J, Vaccaro O, Neaton JD, Wentworth D.The multiple risk factor intervention trial research group: diabetes, other risk factors and 12 year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care1993;16:434–44.
2.
2. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H.Coronary heart disease risk and impaired glucose tolerance. The Whitehall study. Lancet1980;1:1373–6.
3.
3. Colwell JA.Vascular thrombosis in type 2 diabetes mellitus. Diabetes1993;42:8–11.
4.
4. Juhan-Vague I, Alessi MC, Vague P.Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus. Ann Med1996;28:371–80.
5.
5. Pearson JDEndothelial cell function and thrombosis. Baillières Best Pract Res Clin Haematol1999;12:329–41.
6.
6. Goodfellow J, Ramsey MW, Luddington LA et al.Endothelium and inelastic arteries: an early marker of vascular dysfunction in non-insulin dependent diabetes. BMJ1996;312:744–5.
7.
7. Wolf A, Zalpour C, Theilmeier G et al.Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolaemic humans. J Am Coll Cardiol1997;29:479–85.
8.
8. Woods JD, Edwards JS, Ritter JM.Inhibition by nitroprusside of platelet calcium mobilization: evidence for reduced sensitivity to nitric oxide in essential hypertension. J Hypertens1993;11:1369–73.
9.
9. Chirkov YY, Holmes AS, Chirkova LP, Horowitz JD.Nitrate resistance in platelets from patients with stable angina pectoris. Circulation1999;100:129–34.
10.
10. McVeigh G, Brennan G, Hayes R, Johnston D.Primary nitrate tolerance in diabetes mellitus. Diabetologia1994;37:115–17.
11.
11. Vavuranakis M, Stefanadis C, Triandaphyllidi E, Toutouzas K, Toutouzas P.Coronary artery distensibility in diabetic patients with simultaneous measurements of luminal area and intracoronary pressure: evidence of impaired reactivity to nitroglycerin. J Am Coll Cardiol1999;34:1075–81.
12.
12. Tschoepe D, Roesen P, Schwippert B, Gries FA.Platelets in diabetes: the role in the haemostatic regulation in atherosclerosis. Semin Thromb Hemost1993;19:122–8.
13.
13. Anfossi G, Mularoni EM, Burazacca S et al.Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM. Diabetes Care1998;21:121–6.
14.
14. Glassman AB.Platelet abnormalities in diabetes mellitus. Ann Clin Lab Sci1993;23(1):47–50.
15.
15. Oskarsson HJ, Hofmeyer TG.Platelets from patients with diabetes mellitus have impaired ability to mediate vasodilation. J Am Coll Cardiol1996;27:1464–70.
16.
16. Rauch U, Crandall J, Osende JI et al.Increased thrombus formation relates to ambient blood glucose and leukocyte count in type 2 diabetes mellitus. Am J Cardiol2000;86:246–9.
17.
17. Shechter M, Merz CN, Paul-Labrador MJ, Kaul S.Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease. J Am Coll Cardiol2000;35:3000–07.
18.
18. Schaeffer G, Wascher TC, Kostner GM, Graier WF.Alterations in platelet calcium signalling in diabetic patients is due to increased formation of superoxide anions and reduced nitric oxide production. Diabetologia1999;42:167–76.
19.
19. Chirkov YuYu, Tyshchuk IA, Severina IS.Guanylate cyclase in human platelets with different aggregability. Experientia1990;46:697–9.
20.
20. Freese R, Mutanen M.Postprandial changes in platelet function and coagulation factors after high-fat meals with different fatty acid compositions. Eur J Clin Nutr1995;49:658–64.
21.
21. Patsch JR, Miesenbock G, Hopferwieser T et al.Relation of triglyceride metabolism and coronary artery disease. Arterio Thromb1992;12:1336–45.
22.
22. Anderson RA, Evans LM, Ellis GR et al.The relationships between postprandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes. Atherosclerosis2001;154:475–83.
24. Bolli R, Patel BS, Jeroudi MO, Lai EK, McCay PB.Demonstration of free radical generation in ‘stunned” myocardium of intact dogs with the use of the spin trap PBN. JCI1988;82:476–85.
25.
25. Evans JC, Jackson SK.ESR Methods: An ESR and ENDOR study of biological systems using the technique of spin trapping and spin labelling. Anal Proc1990:27:215–17.
26.
26. Mergner GW, Weglicki WB, Kramer JH.Postischaemic free radical production in the venous blood of the regionally ischaemic swine heart. Circulation1991;84:2079–90.
27.
27. Ashton T, Rowlands CC, Jones E et al.Electron spin resonance spectroscopic detection of oxygen-centred radicals in human serum following exhaustive exercise. Eur J Appl Physiol1998;77:498–502.
28.
28. Tortalani AJ, Powell SR, Misik V, Weglicki WB, Pogo GJ, Kramer JH.Detection of alkoxyl and carbon-centred radicals in coronary sinus blood from patients undergoing elective cardioplegia. Free Rad Biol Med1993;14:421–6.
29.
29. Grech ED, Dodd NJF, Jackson MJ, Morrison WL, Faragher EB, Ramsdale DR.Evidence for free radical generation after primary percutaneous transluminal coronary angioplasty recanalization in acute myocardial infarction. Am J Cardiol1996;77:122–7.
30.
30. Esterbauer H, Schaur RJ, Zollner H.Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad Biol Med1991;11:81–128.
31.
31. Ramsey M, Goodfellow J, Jones C, Luddington L, Lewis M, Henderson AH.Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation1995;92:3212–19.
32.
32. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC.Enzymatic determination of total serum cholesterol. Clin Chem1974;20:470–5.
33.
33. Wahlefeld AW.Triglycerides. Determination after enzymatic hydrolysis. Methods of enzymatic analysis. New York: Verlag Chemie Weinheim/Academic Press Inc.1974, 1831–5.
34.
34. John WG, Gray MR, Bates DL, Beacham JL.Enzyme immunoassay — a new technique for estimating haemoglobin A1c. Clin Chem1993;39:663–6.
35.
35. Warnick GR, Nguyen T, Albers AA.Comparison of improved precipitation methods for quantification of HDL cholesterol. Clin Chem1995;31:217–22.
36.
36. Endresen MJ, Tosti E, Heimli H, Lorentzen B, Henriksen T.Effects of free fatty acids found increased in women who develop pre-eclampsia on the ability of endothelial cells to produce prostacyclin, cGMP, and inhibit platelet aggregation. Scand J Clin Lab Invest1994;54:549–57.
37.
37. Evans LM, Anderson RA, Graham J et al.Ciprofibrate therapy improves endothelial function, post-prandial lipaemia, and oxidative stress in type 2 diabetes. Circulation2000;101:1773–9.
38.
38. Lundman P, Eriksson M, Schenck-Gustafsson K, Karpe F, Tornvall P.Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease. Circulation1997;96:3266–8.
